Published in Arteriosclerosis on August 24, 1987
Lipid utilization by human lymphocytes is correlated with high-density-lipoprotein binding site activity. Biochem J (1992) 0.90
Role of cholesterol synthesis and esterification in the growth of CEM and MOLT4 lymphoblastic cells. Biochem J (1997) 0.86
High density lipoproteins stimulate the production and secretion of endothelin-1 from cultured bovine aortic endothelial cells. J Clin Invest (1994) 0.84
The role of apoproteins AI and AII in binding of high-density lipoprotein3 to membranes derived from bovine aortic endothelial cells. Biochem J (1992) 0.79
Differential Expressions of p53, p53R2, hRRM2 and PBR in Chronic Lymphocytic Leukemia: A Correlation with Intracellular Cholesterol. Indian J Clin Biochem (2015) 0.75
Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest (1973) 5.87
The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest (1967) 2.87
The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest (1999) 2.77
Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest (1973) 2.65
Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab (1976) 2.39
Lipoprotein uptake and metabolism by rat aortic smooth muscle cells in tissue culture. Circ Res (1974) 2.20
Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. J Clin Invest (1995) 2.20
Diagnosis and dietary treatment of blood lipid disorders. Med Clin North Am (1970) 2.12
Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis (1973) 1.99
Depletion of plasma-membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts. Biochem J (1988) 1.91
Diabetic lipemia. A form of acquired fat-induced lipemia. N Engl J Med (1967) 1.87
Hypertriglyceridemia. A metabolic consequence of chronic renal failure. N Engl J Med (1968) 1.85
Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction. J Clin Invest (1973) 1.64
Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res (1975) 1.47
Letter: Law of the initial value. Lancet (1976) 1.46
Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J Biol Chem (1991) 1.44
Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. J Clin Invest (1973) 1.38
The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity. J Biol Chem (1981) 1.36
Genetics of hyperlipidemia in coronary heart disease. Trans Assoc Am Physicians (1972) 1.34
Evidence for the chylomicron origin of lipids accumulating in diabetic eruptive xanthomas: a correlative lipid biochemical, histochemical, and electron microscopic study. J Clin Invest (1970) 1.34
Regulation of fatty acid utilization in isolated perfused rat hearts. J Biol Chem (1973) 1.32
Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes. Diabetes Care (1989) 1.29
Effect of a fat free, high carbohydrate diet on diabetic subjects with fasting hyperglycemia. Diabetes (1974) 1.27
Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J Clin Invest (1994) 1.26
Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages. Evidence for reversible binding at the cell surface without internalization. J Biol Chem (1987) 1.26
Is diet the cornerstone in management of diabetes? N Engl J Med (1986) 1.26
Improved glucose tolerance with high carbohydrate feeding in mild diabetes. N Engl J Med (1971) 1.25
Regulation of high density lipoprotein receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells. J Clin Invest (1983) 1.22
Membrane lipid domains distinct from cholesterol/sphingomyelin-rich rafts are involved in the ABCA1-mediated lipid secretory pathway. J Biol Chem (2000) 1.22
Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells. Proc Natl Acad Sci U S A (1993) 1.21
Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism (1976) 1.21
Receptor-dependent uptake of human chylomicron remnants by cultured skin fibroblasts. J Biol Chem (1981) 1.19
Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells. J Biol Chem (1988) 1.19
Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation. J Clin Invest (1979) 1.18
Identification and characterization of a high density lipoprotein-binding protein in cell membranes by ligand blotting. J Biol Chem (1987) 1.14
Abnormal lipid composition of chylomicrons in broad-beta disease (type 3hyperlipoproteinemia). J Clin Invest (1970) 1.13
Binding of high density lipoproteins to cell receptors promotes translocation of cholesterol from intracellular membranes to the cell surface. J Biol Chem (1987) 1.13
Studies on the mechanism of increased plasma triglyceride levels induced by oral contraceptives. N Engl J Med (1969) 1.12
Hyperlipemia and diabetes mellitus. Diabetes (1966) 1.11
Reduced thermic effect of feeding in obesity: role of norepinephrine. Metabolism (1983) 1.11
Platelet-derived growth factor stimulates activity of low density lipoprotein receptors. Proc Natl Acad Sci U S A (1980) 1.11
Carbohydrate and sucrose intake in the causation of atherosclerotic heart disease, diabetes mellitus, and dental caries. Am J Clin Nutr (1979) 1.09
Aggravation of broad- disease (type 3 hyperlipoproteinemia) by hypothyroidism. Arch Intern Med (1972) 1.08
The effect of heparin infusion on plasma triglyceride in vivo and in vitro with a method for calculating triglyceride turnover. J Lab Clin Med (1969) 1.07
Chylomicronemia syndrome. Interaction of genetic and acquired hypertriglyceridemia. Med Clin North Am (1982) 1.07
Specific high-affinity binding of high density lipoproteins to cultured human skin fibroblasts and arterial smooth muscle cells. J Clin Invest (1983) 1.06
Sphingomyelin suppresses the binding and utilization of low density lipoproteins by skin fibroblasts. J Biol Chem (1980) 1.06
Regulatory role of triiodothyronine in the degradation of low density lipoprotein by cultured human skin fibroblasts. J Clin Endocrinol Metab (1979) 1.05
Very low density lipoprotein subfractions in a subject with broad-beta disease (Type 3 hyperlipoproteinemia) and a subject with endogenous lipemia (Type IV). Chemical composition and electrophoretic mobility. Biochim Biophys Acta (1970) 1.05
Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia). Metabolism (1976) 1.04
On the mechanism of action of atromid-S on triglyceride transport in man. Trans Assoc Am Physicians (1970) 1.03
Sterol efflux mediated by endogenous macrophage ApoE expression is independent of ABCA1. Arterioscler Thromb Vasc Biol (2001) 1.03
Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochim Biophys Acta (1999) 1.03
Receptor-mediated transport of cholesterol between cultured cells and high-density lipoproteins. Methods Enzymol (1986) 1.03
Uptake of Lp (a) lipoprotein by cultured fibroblasts. Biochem Biophys Res Commun (1981) 1.02
Abnormal lipid composition of very low density lipoproteins in diagnosis of broad-beta disease (type 3 hyperlipoproteinemia). Metabolism (1972) 1.02
Regulation of long chain fatty acid activation in heart muscle. J Biol Chem (1975) 1.02
Carbohydrate intolerance and lipemia. Ann Intern Med (1968) 1.01
Rapid regulation of the activity of the low density lipoprotein receptor of cultured human fibroblasts. J Biol Chem (1980) 1.01
The effect of donor age on the in vitro life span of cultured human arterial smooth-muscle cells. In Vitro (1978) 1.01
Inhibition of in vivo insulin secretion by prostaglandin E1. J Clin Invest (1974) 0.99
Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis (1987) 0.99
Very low density lipoprotein "remnant" particles: uptake by aortic smooth muscle cells in culture. Biochim Biophys Acta (1973) 0.99
Effect of dietary fructose on triglyceride transport and glucoregulatory hormones in hypertriglyceridemic men. Am J Clin Nutr (1979) 0.99
Abnormal lipoprotein-lipase-mediated plasma triglyceride removal in untreated diabetes mellitus associated with hypertriglyceridemia. Metabolism (1979) 0.98
Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol. Atherosclerosis (2000) 0.98
Effects of high density lipoprotein subfractions on cholesterol homeostasis in human fibroblasts and arterial smooth muscle cells. Arteriosclerosis (1983) 0.97
High density lipoprotein stimulates sterol translocation between intracellular and plasma membrane pools in human monocyte-derived macrophages. J Lipid Res (1989) 0.97
Binding of high density lipoprotein to cultured fibroblasts after chemical alteration of apoprotein amino acid residues. J Biol Chem (1986) 0.96
The effect of hypoxia on uptake and degradation of low density lipoproteins by cultured human arterial smooth muscle cells. Biochim Biophys Acta (1976) 0.96
Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency. Arterioscler Thromb Vasc Biol (1999) 0.96
Regulatory role of insulin in the degradation of low density lipoprotein by cultured human skin fibroblasts. Biochim Biophys Acta (1978) 0.95
Retro-endocytosis of low density lipoprotein by cultured bovine aortic smooth muscle cells. Biochim Biophys Acta (1981) 0.95
Movement of plasma-membrane sterols to the endoplasmic reticulum in cultured cells. Biochem J (1987) 0.94
Up-regulation of high density lipoprotein receptor activity by gamma-interferon associated with inhibition of cell proliferation. J Biol Chem (1988) 0.93
Nonenzymatic glycosylation of HDL and impaired HDL-receptor-mediated cholesterol efflux. Diabetes (1991) 0.93
Acute insulin withdrawal and the regulation of plasma triglyceride removal in diabetic subjects. Diabetes (1968) 0.91
Carbohydrates, sucrose, and human disease. Am J Clin Nutr (1979) 0.91
Reversible abnormalities in postheparin lipolytic activity during the late phase of release in diabetes mellitus (postheparin lipolytic activity in diabetes). Metabolism (1975) 0.90
Uptake of chylomicron remnants causes cholesterol accumulation in cultured human arterial smooth muscle cells. Biochim Biophys Acta (1981) 0.90
Cyclic AMP stimulates efflux of intracellular sterol from cholesterol-loaded cells. J Biol Chem (1993) 0.89
Regulation of low density lipoprotein receptor activity by cultured human arterial smooth muscle cells. Biochim Biophys Acta (1977) 0.89
Oral contraceptives and triglyceride transport: acquired heparin resistance as the mechanism for impaired post-heparin lipolytic activity. J Clin Endocrinol Metab (1972) 0.89
Regulation of high density lipoprotein binding activity of aortic endothelial cells by treatment with acetylated low density lipoprotein. Arteriosclerosis (1985) 0.89
Sounding Board. Diet and coronary heart disease: another view. N Engl J Med (1978) 0.89
Reduction of plasma triglyceride concentration by acute stress in man. Metabolism (1979) 0.88
Steroid-induced lipemia. A complication of high-dosage corticosteroid therapy. Arch Intern Med (1970) 0.88
Evidence for diabetes mellitus and genetic forms of hypertriglyceridemia as independent entities. Metabolism (1975) 0.88